Metraipolis › archive › dc_70a2b43d2f06
A phase II trial of ramucirumab and docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903) — Europe PMC PMID:42081056
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42081056
- DOI
- 10.1007/s10120-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T10:53:03.029Z
- SHA-256 of the archived text
eccbf57ce0dda6e9875c1d6fcd5390cb3e91360330ccf112c558ceb0f76a850c- Stable URL of this page
https://metraipolis.com/documento/dc_70a2b43d2f06
How to cite
A phase II trial of ramucirumab and docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903) — Europe PMC PMID:42081056 — Europe PMC (en), https://europepmc.org/article/MED/42081056 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_70a2b43d2f06 (Metraipolis archive dc_70a2b43d2f06, sha256 eccbf57ce0dda6e9875c1d6fcd5390cb3e91360330ccf112c558ceb0f76a850c)
BibTeX
@misc{dc70a2b43d2f06,
title = {A phase II trial of ramucirumab and docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903) — Europe PMC PMID:42081056},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42081056},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_70a2b43d2f06; sha256 eccbf57ce0dda6e9875c1d6fcd5390cb3e91360330ccf112c558ceb0f76a850c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42081056. Agents can read the archived copy with the MCP tool read_document.